NFKB1 and cancer: It was evident that the combination therapy conducted the inhibition of the GADPH and NF-KB components, leading finally to apoptosis of cancer cells and to an improvement of laboratory parameters such as a decrease in white blood cells and a recovery of the normal balance between lymphocytes, monocytes and eosinophils.